Filing Details
- Accession Number:
- 0001562180-25-005120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-30 17:38:10
- Reporting Period:
- 2025-06-27
- Filing Date:
- 2025-06-30
- Accepted Time:
- 2025-06-30 17:38:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831363 | Terns Pharmaceuticals Inc. | TERN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1563623 | Andrew Gengos | C/O Terns Pharmaceuticals, Inc. 1065 East Hillsdale Blvd., Suite 100 Foster City CA 94404 | Chief Financial Officer | No | No | No | No |
Transaction Summary
| Purchased: | 10,000 shares | Avg. Price: $3.93 | Total Value: $39,283.00 |
| Number of Shares After Transactions: | 25,000 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-27 | 5,000 | $3.93 | 20,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-27 | 5,000 | $3.93 | 25,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
